Lamy F X, Chollet J, Clay E, Brignone M, Rive B, Saragoussi D
Lundbeck SAS , Issy-les-Moulineaux , France.
Curr Med Res Opin. 2015 Apr;31(4):795-807. doi: 10.1185/03007995.2015.1020362. Epub 2015 Mar 16.
To investigate long-term patterns of antidepressant treatment in patients in primary care in the UK, and to assess their healthcare resource use and disease outcomes.
A retrospective longitudinal cohort study was conducted using the Clinical Practice Research Datalink. The study population comprised patients aged ≥18 years with depression receiving a prescription for antidepressant monotherapy between 1 January 2006 and 31 December 2011 with no antidepressants within the preceding 6 months. Recovery was defined by timing of antidepressant prescriptions (≥6 months without treatment). Treatment lines and strategies (switching, combining, augmenting and resuming medication) were analyzed. Healthcare resource use for the different treatment strategies and periods of no therapy was assessed.
Data from 123,662 patients (287,564 treatment lines) were analyzed. Switching and resumption of treatment were more frequent than other strategies. Recovery was highest with first-line monotherapy (45% of patients), while as a second-line strategy switching was more successful (43%) than combination or augmentation. In subsequent lines of treatment, switching was associated with successively lower rates of recovery (31% in the third line and 24% from the fourth line onwards). Similar rates were observed for resumption. Healthcare resource use was greater during antidepressant use than treatment-free periods. Augmentation was associated with the highest proportions of patients with a psychiatrist referral, psychologist referral and psychiatric hospitalization.
This study provides extensive real-world information on the prescribing patterns and treatment outcomes for a large cohort of patients treated for depression with antidepressants in primary care. Switching is more frequently used than augmentation or combination treatment, with decreasing effectiveness across successive lines. Key limitations of the study were: (i) risk of selection bias due to the use of inclusion criteria based on depression diagnoses recorded by the practitioner; and (ii) reliance on prescribing patterns as proxies for clinical outcomes, such as recovery.
调查英国初级医疗中患者抗抑郁药治疗的长期模式,并评估其医疗资源使用情况和疾病转归。
利用临床实践研究数据链进行一项回顾性纵向队列研究。研究人群包括年龄≥18岁、在2006年1月1日至2011年12月31日期间接受抗抑郁药单药治疗处方且在前6个月内未使用过抗抑郁药的抑郁症患者。根据抗抑郁药处方时间(≥6个月未治疗)定义康复情况。分析治疗线和治疗策略(换药、联合用药、增效和恢复用药)。评估不同治疗策略和无治疗期的医疗资源使用情况。
分析了123,662例患者(287,564条治疗线)的数据。换药和恢复用药比其他策略更频繁。一线单药治疗的康复率最高(45%的患者),而作为二线策略,换药比联合用药或增效更成功(43%)。在后续治疗线中,换药的康复率依次降低(三线为31%,四线及以后为24%)。恢复用药的情况类似。抗抑郁药使用期间的医疗资源使用比无治疗期更多。增效与精神科转诊、心理科转诊和精神科住院患者比例最高相关。
本研究为初级医疗中一大群接受抗抑郁药治疗抑郁症患者的处方模式和治疗结果提供了广泛的真实世界信息。换药比增效或联合治疗使用更频繁,且在后续治疗线中疗效降低。本研究的主要局限性为:(i)由于使用基于从业者记录的抑郁症诊断的纳入标准,存在选择偏倚风险;(ii)依赖处方模式作为临床结果(如康复)的替代指标。